Important notification

09.04.2024 To the attention of interested persons Notification regarding professional training and instruction courses for staff with specific duties of […]

Press release

22.03.2024 To the attention of interested persons Synapse Labs Pvt. Ltd: re-examination confirms suspension of medicines over flawed studies download […]

Press release

12.03.2024 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 March 2024 download […]

Important notification

08.03.2024 To the attention of economic operators – taxable persons established in Romania Given the mandatory implementation of the RO […]

Important notification

04.03.2024 To the attention of economic operators requesting issuance/renewal of the operation permit In this section, the National Agency for […]

Important notification

06.02.2024 To the attention of all economic operators We would like to inform you that starting with January 2024, the […]

Important notification

29.01.2024 To the attention of all stakeholders Please be informed that on 23 January 2024, the European Commission published a […]

Press release

12.01.2024 To the attention of interested persons Potential risk of neurodevelopmental disorders in children born to men treated with valproate […]

Press release

12.12.2023 To the attention of interested persons First version of the Union list of critical medicines agreed to help avoid […]

Press release

12.12.2023 To the attention of interested persons Questions and answers on the Union list of critical medicines download document …